Initiation Archives - Page 156 of 272

1 minute read

Loop Capital Initiates Coverage On Sage Therapeutics with Hold Rating, Announces Price Target of $41

November 1, 7:23 AM

Loop Capital analyst Esther Hong initiates coverage on Sage Therapeutics (NASDAQ:SAGE) with a Hold rating and announces Price Target of $41.

SAGE

1 minute read

Jefferies Initiates Coverage On Edap TMS with Buy Rating, Announces Price Target of $11

By Benzinga Newsdesk

November 1, 6:19 AM

Jefferies analyst Michael Sarcone initiates coverage on Edap TMS (NASDAQ:EDAP) with a Buy rating and announces Price Target of $11.

EDAP

1 minute read

EF Hutton Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $27

By Benzinga Newsdesk

November 1, 6:02 AM

EF Hutton analyst Michael King initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target of $27.

BMEA

1 minute read

JP Morgan Initiates Coverage On NorthWestern with Neutral Rating, Announces Price Target of $55

By Benzinga Newsdesk

November 1, 5:31 AM

JP Morgan analyst Brandon Travis initiates coverage on NorthWestern (NASDAQ:NWE) with a Neutral rating and announces Price Target of $55.

NWE

1 minute read

EF Hutton Initiates Coverage On Lantern Pharma with Buy Rating, Announces Price Target of $11

By Benzinga Newsdesk

November 1, 4:55 AM

EF Hutton analyst Michael King initiates coverage on Lantern Pharma (NASDAQ:LTRN) with a Buy rating and announces Price Target of $11.

LTRN

1 minute read

EF Hutton Initiates Coverage On Exelixis with Buy Rating, Announces Price Target of $28

By Benzinga Newsdesk

November 1, 4:54 AM

EF Hutton analyst Michael King initiates coverage on Exelixis (NASDAQ:EXEL) with a Buy rating and announces Price Target of $28.

EXEL

1 minute read

EF Hutton Initiates Coverage On Intellia Therapeutics with Buy Rating, Announces Price Target of $130

By Benzinga Newsdesk

November 1, 4:52 AM

EF Hutton analyst Michael King initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Buy rating and announces Price Target of $130.

NTLA

1 minute read

EF Hutton Initiates Coverage On Jasper Therapeutics with Buy Rating, Announces Price Target of $4

By Benzinga Newsdesk

November 1, 4:46 AM

EF Hutton analyst Michael King initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Buy rating and announces Price Target of $4.

JSPR

1 minute read

Stifel Initiates Coverage On OptimizeRx with Buy Rating, Announces Price Target of $19

By Benzinga Newsdesk

November 1, 4:44 AM

Stifel analyst David Grossman initiates coverage on OptimizeRx (NASDAQ:OPRX) with a Buy rating and announces Price Target of $19.

OPRX

1 minute read

KeyBanc Sees This Woman-Centric Dating Platform Sustaining Growth

By Anusuya Lahiri

October 31, 2:31 PM

KeyBanc analyst Justin Patterson initiated coverage of Bumble Inc (NASDAQ:BMBL) with a Sector Weight rating and no price target. He believed BMBL…

BMBL